Marketers discuss the role of ad safety tech in helping pharma clients feel comfortable with ads in non-endemic media.
Print Issue: May 01, 2018
How pharma and healthcare shifted strategies post-blockbuster drug success
Remedy Health Media’s Mike Collins discusses ways pharma and healthcare companies have shifted their strategies in the years after the success of blockbuster drugs.
Drugs’ value to patients eclipsed by price tags
Like other sectors, pharma is experiencing upheavals no one predicted, and as a result, drugs are being reviled for their price tags, rather than praised for their value.
6 campaigns using real patients as advocates for orphan drugs
Dawn Hastings, associate creative director, Dudnyk, says using patients in campaigns for orphan drugs makes a brand’s audience feel obligated to act.
Health brands need to consider the human side of patients, HCPs, and stakeholders
Croom Lawrence and Kent Groves of Merkle Health explain being human.
Infographic | A closer look at co-pay coupons and programs
Intriguing data on the economics and impact of co-pay coupons and programs
Rbb Communications’ Srikant Ramaswami on yoga, ‘think time,’ and his mentors
Rbb Communications’ EVP of global and emerging markets, healthcare Srikant Ramaswami discusses how he keeps sane with his busy schedule and what inspires him.
Data-driven. Obsessive. A little pushy. Meet this year’s Top 40 Healthcare Transformers
Those on the vanguard of transformation include a number of upstarts and veteran gurus taking on historic challenges plaguing health data.
Top 40 Healthcare Transformers of 2018
Here are the 40 upstarts and veterans who are transforming the healthcare industry.
